Levy Adam Scott
SEC insider (Form 3/4/5 filer). CIK 0001693134. CFO and Secretary at Mineralys Therapeutics, Inc. (MLYS). 27 reported Form 4/5 transactions since Sep 2024; latest on Feb 19, 2026. Located in RADNOR, PA.
Companies Levy Adam Scott has filed insider reports for
- Mineralys Therapeutics, Inc. (MLYS): Officer, CFO and Secretary
Levy Adam Scott
CIK: 0001693134
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Mineralys Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (27 total)
- Feb 19, 2026MLYS
Mineralys Therapeutics, Inc.
AwardDirect39.9K shares- - Jan 12, 2026MLYS
Mineralys Therapeutics, Inc.
SaleDirect10.8K shares at avg. $32.14$346K - Nov 11, 2025MLYS
Mineralys Therapeutics, Inc.
ExerciseDirect34.4K shares at avg. $16.00$551K - Nov 11, 2025MLYS
Mineralys Therapeutics, Inc.
ExerciseDirect20.5K shares at avg. $10.20$210K - Nov 11, 2025MLYS
Mineralys Therapeutics, Inc.
ExerciseDirect6.6K shares at avg. $15.44$102K - Nov 11, 2025MLYS
Mineralys Therapeutics, Inc.
ExerciseDirect44.1K shares at avg. $14.25$628K - Nov 11, 2025MLYS
Mineralys Therapeutics, Inc.
SaleDirect1.6K shares at avg. $42.68$67K - Nov 11, 2025MLYS
Mineralys Therapeutics, Inc.
SaleDirect1K shares at avg. $42.00$43K - Nov 11, 2025MLYS
Mineralys Therapeutics, Inc.
SaleDirect11.3K shares at avg. $41.87$473K - Nov 11, 2025MLYS
Mineralys Therapeutics, Inc.
SaleDirect13K shares at avg. $41.65$539K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 19, 2026 | MLYS Mineralys Therapeutics, Inc. | Award | 39,900 | - | $0 | Direct |
| Jan 12, 2026 | MLYS Mineralys Therapeutics, Inc. | Sale | 10,758 | $32.14 | $345,723 | Direct |
| Nov 11, 2025 | MLYS Mineralys Therapeutics, Inc. | Exercise | 34,414 | $16.00 | $550,624 | Direct |
| Nov 11, 2025 | MLYS Mineralys Therapeutics, Inc. | Exercise | 20,547 | $10.20 | $209,579 | Direct |
| Nov 11, 2025 | MLYS Mineralys Therapeutics, Inc. | Exercise | 6,613 | $15.44 | $102,105 | Direct |
| Nov 11, 2025 | MLYS Mineralys Therapeutics, Inc. | Exercise | 44,079 | $14.25 | $628,126 | Direct |
| Nov 11, 2025 | MLYS Mineralys Therapeutics, Inc. | Sale | 1,561 | $42.68 | $66,623 | Direct |
| Nov 11, 2025 | MLYS Mineralys Therapeutics, Inc. | Sale | 1,015 | $42.00 | $42,630 | Direct |
| Nov 11, 2025 | MLYS Mineralys Therapeutics, Inc. | Sale | 11,295 | $41.87 | $472,932 | Direct |
| Nov 11, 2025 | MLYS Mineralys Therapeutics, Inc. | Sale | 12,952 | $41.65 | $539,479 | Direct |
1-10 of 27 transactions